Your browser doesn't support javascript.
loading
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
McCallum, Matthew; Bassi, Jessica; De Marco, Anna; Chen, Alex; Walls, Alexandra C; Di Iulio, Julia; Tortorici, M Alejandra; Navarro, Mary-Jane; Silacci-Fregni, Chiara; Saliba, Christian; Sprouse, Kaitlin R; Agostini, Maria; Pinto, Dora; Culap, Katja; Bianchi, Siro; Jaconi, Stefano; Cameroni, Elisabetta; Bowen, John E; Tilles, Sasha W; Pizzuto, Matteo Samuele; Guastalla, Sonja Bernasconi; Bona, Giovanni; Pellanda, Alessandra Franzetti; Garzoni, Christian; Van Voorhis, Wesley C; Rosen, Laura E; Snell, Gyorgy; Telenti, Amalio; Virgin, Herbert W; Piccoli, Luca; Corti, Davide; Veesler, David.
Afiliação
  • McCallum M; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Chen A; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Di Iulio J; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Navarro MJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Silacci-Fregni C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Saliba C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Agostini M; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Bianchi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Jaconi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Tilles SW; Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  • Guastalla SB; Independent physician, 6828 Balerna, Switzerland.
  • Bona G; Clinical Research Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
  • Pellanda AF; Clinical Research Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
  • Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
  • Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Rosen LE; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Snell G; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Telenti A; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Virgin HW; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. lpiccoli@vir.bio dcorti@vir.bio dveesler@uw.edu.
  • Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. lpiccoli@vir.bio dcorti@vir.bio dveesler@uw.edu.
  • Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. lpiccoli@vir.bio dcorti@vir.bio dveesler@uw.edu.
Science ; 373(6555): 648-654, 2021 08 06.
Article em En | MEDLINE | ID: mdl-34210893
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_pneumonia Assunto principal: Evasão da Resposta Imune / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD Problema de saúde: 4_pneumonia Assunto principal: Evasão da Resposta Imune / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos